Dr. Charlotte Owens, MD, Therapeutic Area Lead for Women’s Health in U.S. Medical Affairs at AbbVie discusses new data presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting on Real-World findings on elagolix in endometriosis and uterine fibroids. Data highlights include positive treatment effects in endometriosis-associated pain, and higher physician satisfaction than other currently available treatments.
Dr. Charlotte Owens is a board-certified obstetrician and gynecologist and the Therapeutic Area Lead for Women’s Health in U.S. Medical Affairs at AbbVie. Dr. Owens oversees the scientific communications, field medical science liaison team, clinical trials, educational efforts and publications for Women’s Health efforts at AbbVie. Dr. Owens recently served as the Senior Medical Director in Clinical Development at AbbVie, and was responsible for helping lead the direction, planning, execution and interpretation of clinical trials in women’s health issues to deliver robust clinical data. She also serves as an adjunct clinical assistant professor at the Morehouse School of Medicine.